Bristol Myers Squibb Net Profit Margin 2006-2021 | BMY

Current and historical net profit margin for Bristol Myers Squibb (BMY) from 2006 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue. Bristol Myers Squibb net profit margin for the three months ending September 30, 2021 was .
Bristol Myers Squibb Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2021-09-30 $45.47B $-5.41B -11.89%
2021-06-30 $44.38B $-5.08B -11.44%
2021-03-31 $42.81B $-6.22B -14.53%
2020-12-31 $42.52B $-9.02B -21.20%
2020-09-30 $39.40B $-0.04B -0.11%
2020-06-30 $34.86B $-0.56B -1.61%
2020-03-31 $31.01B $0.95B 3.08%
2019-12-31 $26.15B $3.44B 13.15%
2019-09-30 $24.17B $5.66B 23.39%
2019-06-30 $23.86B $6.20B 26.00%
2019-03-31 $23.29B $5.14B 22.09%
2018-12-31 $22.56B $4.92B 21.81%
2018-09-30 $22.04B $1.43B 6.50%
2018-06-30 $21.60B $0.38B 1.74%
2018-03-31 $21.04B $0.92B 4.37%
2017-12-31 $20.78B $1.01B 4.85%
2017-09-30 $20.57B $4.23B 20.56%
2017-06-30 $20.24B $4.59B 22.66%
2017-03-31 $19.97B $4.84B 24.22%
2016-12-31 $19.43B $4.46B 22.94%
2016-09-30 $18.47B $3.37B 18.22%
2016-06-30 $17.62B $2.87B 16.29%
2016-03-31 $16.91B $1.57B 9.31%
2015-12-31 $16.56B $1.57B 9.45%
2015-09-30 $16.53B $1.78B 10.74%
2015-06-30 $16.38B $1.79B 10.93%
2015-03-31 $16.11B $2.25B 13.99%
2014-12-31 $15.88B $2.00B 12.62%
2014-09-30 $16.06B $2.72B 16.92%
2014-06-30 $16.21B $2.69B 16.59%
2014-03-31 $16.37B $2.89B 17.67%
2013-12-31 $16.39B $2.56B 15.64%
2013-09-30 $16.14B $2.76B 17.11%
2013-06-30 $15.81B $1.36B 8.59%
2013-03-31 $16.20B $1.47B 9.05%
2012-12-31 $17.62B $1.96B 11.12%
2012-09-30 $18.88B $1.89B 9.98%
2012-06-30 $20.49B $3.56B 17.39%
2012-03-31 $21.48B $3.82B 17.77%
2011-12-31 $21.24B $3.70B 17.42%
2011-09-30 $20.90B $3.32B 15.89%
2011-06-30 $20.35B $3.30B 16.23%
2011-03-31 $19.69B $3.33B 16.92%
2010-12-31 $19.48B $3.09B 15.86%
2010-09-30 $19.41B $10.63B 54.76%
2010-06-30 $19.40B $10.64B 54.87%
2010-03-31 $19.29B $10.70B 55.46%
2009-12-31 $18.81B $10.59B 56.33%
2009-09-30 $16.14B $3.83B 23.73%
2009-06-30 $16.61B $5.44B 32.77%
2009-03-31 $17.15B $5.22B 30.47%
2008-12-31 $17.72B $5.25B 29.62%
2008-09-30 $17.58B $3.91B 22.27%
2008-06-30 $16.92B $2.19B 12.96%
2008-03-31 $16.19B $2.14B 13.19%
2007-12-31 $15.62B $2.17B 13.86%
2007-09-30 $15.90B $2.12B 13.34%
2007-06-30 $15.45B $1.60B 10.36%
2007-03-31 $15.85B $1.56B 9.85%
2006-12-31 $16.21B $1.59B 9.78%
2006-09-30 $18.12B $2.22B 12.24%
2006-06-30 $18.73B $2.84B 15.18%
2006-03-31 $18.75B $3.18B 16.97%
2005-12-31 $18.61B $3.00B 16.12%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $141.747B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
QIAGEN (QGEN) Netherlands $10.791B 18.27
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88